4.87
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt SLS?
Forum
Prognose
Aktiensplit
Sellas Life Sciences Group Inc Aktie (SLS) Neueste Nachrichten
SLS stock kicks off week in green: CEO flags role in EU biotech policy talks that could impact drug approvals - MSN
SLS Stock Kicks Off Week In Green: CEO Flags Role In EU Biotech Policy Talks That Could Impact Drug Approvals - Stocktwits
SLS stock slips after-hours as cancer pipeline silence frustrates retail — China licensing fight now in spotlight - MSN
SLS Stock Tests $5 Again: Retail Targets ‘No’ Vote On 20M Share Dilution Push Before AML Trial Results - Stocktwits
SLS stock gains momentum: NVDA, MSFT investor loads up ahead of AML trial milestone trigger - MSN
Sellas Life Sciences draws significant retail buzz as traders eye REGAL phase 3 catalyst – SLS stock soars 15% - MSN
SLS News | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
SLS stock sparks retail buzz ahead of AACR presentation on experimental cancer therapy - MSN
SLS stock jumps premarket: US investor Dagco boosts stake by 78% ahead of fresh cancer drug data reveal - MSN
SLS Forecast, Price Target & Analyst Ratings | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - ChartMill
SLS stock jumps overnight: ‘potent’ AML drug data ahead of cancer summit fuels fresh momentum - MSN
SELLAS Life Sciences Group (SLS) price target increased by 15.38% to 10.20 - MSN
SELLAS LIFE SCIENCES GROUP, INC. (SLS) - MSN
SLS stock rises premarket ahead of cancer summit this month – investors eye phase 3 AML trial milestone - MSN
SELLAS Life Sciences Group (SLS) price target increased by 26.83% to 8.84 - MSN
SLS Stock Gains Momentum: NVDA, MSFT Investor Loads Up Ahead Of AML Trial Milestone Trigger - Stocktwits
SLS stock jumps overnight: CEO doubles down on ‘steadfast’ confidence in AML drug and pushes for 20M share plan approval - MSN
SLS stock rallies ahead of AML trial readout — 'Pharma Bro' Martin Shkreli says he's still 'very bearish,' predicts drug will fail - MSN
SLS Stock Holds Support As Cash Pile Fuels Biotech Bounce - StocksToTrade
Wall Street analysts think SELLAS Life Sciences Group, Inc. (SLS) could surge 66.09%: Read this before placing a bet - MSN
SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants - MSN
SLS Stock Jumps Overnight: CEO Doubles Down On ‘Steadfast’ Confidence In AML Drug And Pushes For 20M Share Plan Approval - Stocktwits
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):